日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit-The EU Regulator's Perspective

在评估显著疗效时,如何界定罕见病治疗的满意方法——欧盟监管机构的视角

Sheean, Maria E; Naumann-Winter, Frauke; Capovilla, Giuseppe; Kalland, Maria Elisabeth; Malikova, Eva; Mariz, Segundo; Matusevicius, Darius; Nistico, Robert; Schwarzer-Daum, Brigitte; Tsigkos, Stelios; Tzogani, Kyriaki; Larsson, Kristina; Magrelli, Armando; Stoyanova-Beninska, Violeta

Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination.

MAPK 的激活会抑制髓鞘生长,并在雪旺细胞发育和髓鞘形成过程中取代 Nrg1/ErbB3 信号

Sheean Maria E, McShane Erik, Cheret Cyril, Walcher Jan, Müller Thomas, Wulf-Goldenberg Annika, Hoelper Soraya, Garratt Alistair N, Krüger Markus, Rajewsky Klaus, Meijer Dies, Birchmeier Walter, Lewin Gary R, Selbach Matthias, Birchmeier Carmen